One year of COVID-19 pandemic: Health care workers' infection rates and economical burden in medical facilities for oral and maxillofacial surgery.

Aerosol COVID-19 Healthcare workers Oral and maxillofacial surgery Personal protective equipment Pre-interventional testing

Journal

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
ISSN: 1878-4119
Titre abrégé: J Craniomaxillofac Surg
Pays: Scotland
ID NLM: 8704309

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 14 12 2021
revised: 26 07 2022
accepted: 14 10 2022
pubmed: 20 11 2022
medline: 15 12 2022
entrez: 19 11 2022
Statut: ppublish

Résumé

The aim of this study was to create an overview on the COVID-associated burdens faced by the oral and maxillofacial surgery (OMS) workforce during 1 year of the pandemic. OMS hospitals and private practices nationwide were surveyed regarding health care worker (HCW) screening, infection status, pre-interventional testing, personal protective equipment (PPE), and economic impact. Participants were recruited via the German Society for Oral and Maxillofacial Surgery. A total of 11 hospitals (416 employees) and 55 private practices (744 employees) participated. The HCW infection rate was significantly higher in private practices than in clinics (4.7% vs. 1.4%, p<0.01), although most infections in HCW occurred in private environment (hospitals 88.2%, private practice 66.7%). Pre-interventional testing was performed significantly less for outpatients in private practices than in hospitals (90.7% vs. 36.4%, p<0.01). Polymerase chain reaction (PCR) was used significantly more for inpatients in hospitals than in private practices (100.0% vs. 27.3%, p<0.01). FFP2/3 use rose significantly in hospitals (0% in second quarter vs. 46% in fourth quarter, p<0.05) and private practices (15% in second quarter vs. 38% in fourth quarter, p<0.01). The decrease in procedures (≤50%) was significantly higher in hospitals than in private practices (90.9% vs. 40.0%, p<0.01). Despite higher infection rates in private practices, declining procedures and revenue affected hospitals more. Future COVID-related measures must adjust the infrastructure especially for hospitals to prevent further straining of staff and finances.

Identifiants

pubmed: 36402637
pii: S1010-5182(22)00156-1
doi: 10.1016/j.jcms.2022.10.001
pmc: PMC9637287
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

831-836

Informations de copyright

Copyright © 2022 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflicts of interest.

Références

J Fluid Mech. 2020 Sep 28;903:F1
pubmed: 34191877
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
J Craniomaxillofac Surg. 2022 May;50(5):462-467
pubmed: 35430134
Int J Infect Dis. 2021 Jan;102:239-241
pubmed: 33130210
J Hosp Infect. 2020 Apr 26;:
pubmed: 32348833
Antimicrob Resist Infect Control. 2020 Dec 7;9(1):192
pubmed: 33287908
Br J Oral Maxillofac Surg. 2020 Jul;58(6):704-707
pubmed: 32513429
Clin Oral Investig. 2021 Aug;25(8):5001-5008
pubmed: 33543382
BMC Surg. 2020 Dec 3;20(1):313
pubmed: 33272227
Lancet Infect Dis. 2020 Oct;20(10):e261-e267
pubmed: 32711692
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Int J Prev Med. 2013 May;4(5):611-5
pubmed: 23930175
J Craniomaxillofac Surg. 2020 May;48(5):521-526
pubmed: 32303420
J Craniomaxillofac Surg. 2022 Apr;50(4):380-387
pubmed: 35279344
J Virol Methods. 2021 Mar;289:114033
pubmed: 33285192
BDJ Open. 2020 Nov 24;6:25
pubmed: 33251028
BMC Infect Dis. 2021 Aug 10;21(1):798
pubmed: 34376187
J Craniomaxillofac Surg. 2021 Apr;49(4):323-328
pubmed: 33581957
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
SN Compr Clin Med. 2020;2(12):2540-2545
pubmed: 33134846
Environ Int. 2020 Sep;142:105832
pubmed: 32521345
JAMA Intern Med. 2020 Oct 1;180(10):1328-1333
pubmed: 32744612

Auteurs

Ella Bachmann (E)

Department of Oral and Maxillofacial Surgery, University Hospital Augsburg, Sauerbruchstraße 6, 86179, Augsburg, Germany. Electronic address: ella.bachmann@uk-augsburg.de.

Stephan Zellmer (S)

Department of Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

Maria Kahn (M)

Department of Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

Anna Muzalyova (A)

Department of Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

Alanna Ebigbo (A)

Department of Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

Bilal Al-Nawas (B)

Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Centre of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Thomas Ziebart (T)

Department of Oral and Maxillofacial Surgery, University Hospital Marburg UKGM GmbH, Marburg, Germany.

Axel Meisgeier (A)

Department of Oral and Maxillofacial Surgery, University Hospital Marburg UKGM GmbH, Marburg, Germany.

Claudia Traidl-Hoffmann (C)

Department of Environmental Medicine, Faculty of Medicine, University of Augsburg, Neusäßer Straße 47, 86156, Augsburg, Germany.

Fabian Eckstein (F)

Department of Oral and Maxillofacial Surgery, University Hospital Hannover, Hannover, Germany.

Helmut Messmann (H)

Department of Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

Tilo Schlittenbauer (T)

Department of Oral and Maxillofacial Surgery, University Hospital Augsburg, Sauerbruchstraße 6, 86179, Augsburg, Germany.

Christoph Römmele (C)

Department of Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH